Back to
Skandinaviska Enskilda Banken AB (publ)
KNTE2 quarters
Position history for
Skandinaviska Enskilda Banken AB (publ)'s holdings in KINNATE BIOPHARMA INC
Skandinaviska Enskilda Banken AB (publ) previously held 0 shares of KNTE (KINNATE BIOPHARMA INC), worth $0 as of 2024-Q2.
Final Value
$0
Final Shares
0
Total Value Change
-$136,192
Total Shares Change
-51,200
Quarter-by-Quarter History
Other major holders of KNTE: RA CAPITAL MANAGEMENT, L.P., VIKING GLOBAL INVESTORS LP